Phage-based Antimicrobial Resistance-sensitizing Solutions
Trobix Bio is an Israeli biotech company pioneering the field of human microbiome via its TBX™ technology platform, utilizing CRISPR, phage and synthetic biology to re-program specific activities in targeted microbiome bacteria and develop orally administered precision oncology therapeutics. Targeting cumulative markets of over $4 billion, Trobix’s preclini…